William Cavanagh - Chief R&D Officer at Perspective Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief R&D Officer
Issuer Symbol
CATX on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by William Cavanagh since 20 Jan 2025

Holdings reported by William Cavanagh for Perspective Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (right to buy) 1,493,846 21 Jul 2022 Direct Common Stock

Transactions reported by William Cavanagh for Perspective Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.